These data indicate that JMJD3 inactivation leads to worsening renal fibrosis, in contrast to the anti-fibrotic effect of EZH2 inhibition, and suggest that injury-induced JMJD3 activation is a defensive response by the kidney to limit renal fibrosis. This evidence concerns the gene KDM6B and renal fibrosis.